Carlos A Labarrere,John R Woods,Miguel A Ortiz et al.
Carlos A Labarrere et al.
Emergency surgical treatment of advanced endomyocardial fibrosis in Mozambique [0.03%]
莫桑比克终末期心内膜纤维化的外科治疗急诊手术经验
Ana Olga Mocumbi,Carla Carrilho,Margaret M Burke et al.
Ana Olga Mocumbi et al.
Background: An 11-year-old girl presented to a specialist cardiac facility in Mozambique. She had severe heart failure and massive cardiac enlargement, herniation of the heart into the epigastrium, atrial fibrillation, si...
Prospective, observational study of antiplatelet and coagulation biomarkers as predictors of thromboembolic events after implantation of ventricular assist devices [0.03%]
前瞻性观察研究抗血小板和凝血生物标志物作为植入式静脉辅助装置后血栓栓塞事件的预测因素
Farhan Majeed,Willem J Kop,Robert S Poston et al.
Farhan Majeed et al.
Background: Long-term success in ventricular assist device (VAD) recipients is limited by thromboembolic events, the prediction of which remains elusive. We evaluated the predictive value of aspirin hyporesponsiveness and...
Valentin Fuster
Valentin Fuster
Cross-sectional, prospective study of MRI reproducibility in the assessment of plaque burden of the carotid arteries and aorta [0.03%]
横断面及前瞻性的研究评估颈动脉和腹主动脉斑块负担的MRI重复性
Hamza El Aidi,Venkatesh Mani,Karen B Weinshelbaum et al.
Hamza El Aidi et al.
Background: The reliability of imaging techniques to assess early atherosclerosis remains unclear. We did a cross-sectional, prospective study to test reproducibility of MRI when imaging arteries, to assess risk of cardio...
Primary prevention of cardiovascular events in diabetes: is there a role for aspirin? [0.03%]
糖尿病患者心血管事件的一级预防：阿司匹林的作用
Hermione C Price,Rury R Holman
Hermione C Price
The POPADAD (Prevention Of Progression of Arterial Disease And Diabetes) study did not show a benefit for low-dose aspirin therapy or administration of antioxidants for the primary prevention of cardiovascular disease events in individuals ...
Is intravenous recombinant plasminogen activator effective up to 4.5 h after onset of ischemic stroke? [0.03%]
在缺血性卒中发生后4.5小时内使用静脉注射重组组织型纤溶酶原激活物有效吗？
Peter M Rothwell
Peter M Rothwell
Randomized, controlled trials and subsequent observational studies in routine clinical practice have shown that intravenous recombinant tissue plasminogen activator is safe and effective when used in selected patients within 3h of the onset...
Stephen Westaby
Stephen Westaby
Antiphospholipid antibodies from a patient with primary antiphospholipid syndrome enhance experimental atherosclerosis [0.03%]
自身抗磷脂综合征患者来源的抗磷脂抗体可促进实验性动脉粥样硬化进展
Arnon Adler,Arnon Afek,Yair Levy et al.
Arnon Adler et al.
Background: A 35-year-old man with primary antiphospholipid syndrome and no risk factors for atherosclerosis presented with postinfarction angina. Investi...
The emerging role of cardiovascular magnetic resonance in refining the diagnosis of hypertrophic cardiomyopathy [0.03%]
心血管磁共振在肥厚型心肌病诊断中的作用不容忽视
James C Moon,William J McKenna
James C Moon
Hypertrophic cardiomyopathy (HCM) is a genetically and phenotypically diverse disease with some patients at risk of sudden death or heart failure. Maron et al. used cardiovascular magnetic resonance, in a specialist clinic setting, to ident...